Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -108.87x is in line with its 1-year average of -108.96x, near the high end of its 1-year range (-240.71x–-57.13x).
0.08% above its 12-month average of -108.96x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -84.34x.
INTEREST COVERAGE RATIO
-108.87x
INTEREST COVERAGE RATIO AVG TTM
-108.96x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+0.08%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.23x
median of 360 covered companies
CURRENT VS SECTOR MEDIAN
-2473.76%
vs the sector median at left
Cogent Biosciences, Inc.
Market Cap
$5.16B
Interest Coverage Ratio
-108.87x
TTM Avg
-108.96x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.11B
Interest Coverage Ratio
-55.80x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.13B
Interest Coverage Ratio
6.97x
TTM Avg
5.98x
3Y Avg
8.44x
5Y Avg
9.07x
Market Cap
$5.29B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.91B
Interest Coverage Ratio
168.66x
TTM Avg
168.66x
3Y Avg
168.66x
5Y Avg
168.66x
Market Cap
$4.86B
Interest Coverage Ratio
-1.54x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.57B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | $5.16B | -108.87x | -108.96x | N/A | N/A |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.11B | -55.80x | N/A | N/A | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.13B | 6.97x | 5.98x | 8.44x | 9.07x |
| Doximity, Inc. (DOCS)vs › | $5.36B | N/A | N/A | N/A | N/A |
| CRISPR Therapeutics AG (CRSP)vs › | $5.29B | N/A | N/A | N/A | N/A |
| Erasca, Inc. (ERAS)vs › | $4.93B | N/A | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $4.91B | 168.66x | 168.66x | 168.66x | 168.66x |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.86B | -1.54x | N/A | N/A | N/A |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.57B | N/A | N/A | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.71B | N/A | N/A | N/A | N/A |
Interest Coverage
-108.9x
Debt/Equity
0.46
Current Ratio
13.57
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -84.34x |
| 2026-03-31 | -85.41x |
| 2025-12-31 | -77.19x |
| 2025-09-30 | -57.13x |
| 2025-06-30 | -240.71x |
